RFCA
MRK icon

R&F Capital Advisors’s Merck MRK Stock Holding History

R&F Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$218K Sell
3,593
-4,695
-57% -$285K 0.06% 526
2016
Q4 		$466K Buy
+8,288
New +$485K 0.16% 195

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

R&F Capital Advisors's MRK Position: Q1 2017 in Review

R&F Capital Advisors reduced its Merck (MRK) stake by 57% in Q1 2017, selling an estimated $285K and leaving 3,593 shares worth $218K. The position accounts for 0.06% of the portfolio, ranked #526.

R&F Capital Advisors first reported a position in MRK in Q4 2016 and has held it in 2 quarters since. The position peaked at $466K in Q4 2016. 1,942 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • R&F Capital Advisors held 3,593 shares of Merck worth $218K as of Q1 2017.
  • R&F Capital Advisors sold 4,695 Merck shares in Q1 2017, an estimated $285K.
  • Merck made up 0.06% of R&F Capital Advisors's portfolio in Q1 2017, its #526 holding.
  • R&F Capital Advisors first reported a position in Merck in Q4 2016 and has held it in 2 quarters since.
  • R&F Capital Advisors's Merck position peaked at $466K in Q4 2016.
  • 1,942 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.